FI890127A - Menetelmä terapeuttisesti käyttökelpoisen hirudiinijohdannaisen valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisen hirudiinijohdannaisen valmistamiseksi Download PDF

Info

Publication number
FI890127A
FI890127A FI890127A FI890127A FI890127A FI 890127 A FI890127 A FI 890127A FI 890127 A FI890127 A FI 890127A FI 890127 A FI890127 A FI 890127A FI 890127 A FI890127 A FI 890127A
Authority
FI
Finland
Prior art keywords
preparing
hirudin derivative
therapeutically useful
hirudin
derivative
Prior art date
Application number
FI890127A
Other languages
English (en)
Swedish (sv)
Other versions
FI96956B (fi
FI890127A0 (fi
FI96956C (fi
Inventor
Peter Crause
Paul Habermann
Dominique Tripier
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25865106&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI890127(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from HU851341A external-priority patent/HU198085B/hu
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI890127A0 publication Critical patent/FI890127A0/fi
Publication of FI890127A publication Critical patent/FI890127A/fi
Publication of FI96956B publication Critical patent/FI96956B/fi
Application granted granted Critical
Publication of FI96956C publication Critical patent/FI96956C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/815Protease inhibitors from leeches, e.g. hirudin, eglin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI890127A 1985-04-11 1989-01-11 Menetelmä terapeuttisesti käyttökelpoisen hirudiinijohdannaisen valmistamiseksi FI96956C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
HU851341A HU198085B (en) 1984-04-18 1985-04-11 Process for producing new hirudine derivatives with anticoagulant effect and pharmaceutical compositions comprising same as active ingredient
HU134185 1985-04-11
DE3805540 1988-02-23
DE3805540 1988-02-23

Publications (4)

Publication Number Publication Date
FI890127A0 FI890127A0 (fi) 1989-01-11
FI890127A true FI890127A (fi) 1989-07-14
FI96956B FI96956B (fi) 1996-06-14
FI96956C FI96956C (fi) 1996-09-25

Family

ID=25865106

Family Applications (1)

Application Number Title Priority Date Filing Date
FI890127A FI96956C (fi) 1985-04-11 1989-01-11 Menetelmä terapeuttisesti käyttökelpoisen hirudiinijohdannaisen valmistamiseksi

Country Status (9)

Country Link
EP (1) EP0324712B1 (fi)
AT (1) ATE87938T1 (fi)
DE (2) DE19775033I2 (fi)
DK (1) DK172350B1 (fi)
ES (1) ES2055149T3 (fi)
FI (1) FI96956C (fi)
IL (1) IL88925A (fi)
LU (1) LU90127I2 (fi)
NL (1) NL970027I2 (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3835815A1 (de) * 1988-10-21 1990-04-26 Hoechst Ag Neue isohirudine
EP0502962B1 (de) * 1989-12-01 1996-03-13 BASF Aktiengesellschaft Hirudin-Muteine und deren Polyalkylenglykolkonjugate
DE4140381A1 (de) * 1991-12-07 1993-06-09 Hoechst Ag, 6230 Frankfurt, De Neue synthetische isohirudine mit verbesserter stabilitaet
DE4404168A1 (de) * 1994-02-10 1995-08-17 Hoechst Ag Hirudinderivate und Verfahren zu deren Herstellung
DE19529997C1 (de) 1995-08-16 1997-04-10 Hoechst Ag Verfahren zur Inaktivierung von Carboxypeptidase Y in hirudinhaltigen Kulturbrühen
DE19543737A1 (de) * 1995-11-24 1997-05-28 Hoechst Ag Verfahren zur Ultrafiltration von Peptide oder Proteine enthaltender biologischer Matrices
DE19544233A1 (de) 1995-11-28 1997-06-05 Hoechst Ag Verfahren zur Nutzung des Hefe-ADH II-Promotorsystems zur biotechnologischen Produktion heterologer Proteine in hohen Ausbeuten
DE69625623T2 (de) 1996-01-31 2003-11-06 Sumitomo Bakelite Co. Ltd., Tokio/Tokyo Verfahren zur Herstellung von in Epoxyharz eingekapselter Halbleitervorrichtung
DE19607239A1 (de) 1996-02-27 1997-08-28 Behringwerke Ag Pharmazeutische Zusammensetzung, enthaltend Hirudin und Verfahren zu deren Herstellung
DE19944870A1 (de) 1999-09-18 2001-03-29 Aventis Pharma Gmbh Signalsequenzen zur Herstellung von Leu-Hirudin über Sekretion durch E. coli in das Kulturmedium
DE10033195A1 (de) * 2000-07-07 2002-03-21 Aventis Pharma Gmbh Bifunktionale Fusionsproteine aus Hirudin und TAP
US7638618B2 (en) 2001-02-20 2009-12-29 Sanofi-Aventis Deutschland Gmbh Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
US7202059B2 (en) 2001-02-20 2007-04-10 Sanofi-Aventis Deutschland Gmbh Fusion proteins capable of being secreted into a fermentation medium
JP2006096668A (ja) * 2002-11-08 2006-04-13 Ono Pharmaceut Co Ltd エラスターゼ阻害剤と血液凝固系および/または線溶系酵素阻害剤との組み合わせからなる医薬

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3438296A1 (de) * 1984-04-18 1985-11-07 Hoechst Ag, 6230 Frankfurt Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel
DE3689525D1 (de) * 1985-07-17 1994-02-24 Hoechst Ag Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel.

Also Published As

Publication number Publication date
NL970027I2 (nl) 1998-04-01
DK13189A (da) 1989-07-14
DK172350B1 (da) 1998-04-06
ES2055149T3 (es) 1994-08-16
DE19775033I2 (de) 2011-01-20
DE58903988D1 (de) 1993-05-13
DK13189D0 (da) 1989-01-12
ATE87938T1 (de) 1993-04-15
EP0324712A2 (de) 1989-07-19
EP0324712B1 (de) 1993-04-07
IL88925A (en) 1995-11-27
LU90127I2 (fr) 1997-10-06
FI96956B (fi) 1996-06-14
FI890127A0 (fi) 1989-01-11
NL970027I1 (nl) 1997-10-01
EP0324712A3 (en) 1990-07-04
FI96956C (fi) 1996-09-25

Similar Documents

Publication Publication Date Title
FI890127A (fi) Menetelmä terapeuttisesti käyttökelpoisen hirudiinijohdannaisen valmistamiseksi
KR880701557A (ko) 변형인자 ⅷ:c 및 변형인자ⅷ:c-유사 폴리펠티드를 코오딩하는 dna서열 및 이들 폴리펩티드를 고수율로 제조하는 방법
IT8167406A0 (it) Procedimento e veicolo per la produzione di polipeptidi mediante espressione nei batteri di un codice genetico di struttura
PT83761B (pt) Metodo para a producao de interleuquina-4 de mamifero
DK0382173T3 (da) Substans PF 1022, fremgangsmåde til fremstilling heraf og anthelmintisk præparat indeholdende denne
NO895028D0 (no) Ny chimerisk transformerende vekstfaktor-beta.
IT1231549B (it) Procedimento per la produzione di semilavorati di cuoio
DK0655454T3 (da) Fremgangsmåde til fremstilling af 2,2-difluorketensilylacetaler og alfa,alfa-difluor-beta-silyloxy-1,3-dioxolan-4-propansyreestere
EP0712928A3 (fi)
NO861635L (no) Fremgangsmaate for fremstilling av rekombinert aaa-interferon.
IE791378L (en) Alpha-difluoromethyl amino acids
SE8403929D0 (sv) Recombinant dna molecule, transformed microorganisms and process for producing penicillin v amidase
ATE48641T1 (de) Ein menschlicher t-zellwachstumsfaktor.
DK628188A (da) Protein og fremgangsmaade til fremstilling deraf
NO166413C (no) Fremgangsmaate ved anvendelse av et anlegg for direkte destillasjon i kombinasjon med en hydrostrippingsprosess.
DK0433845T3 (da) Fremgangsmåde til fremstilling af 2-acylamino-9-acyl-6-halogen-puriner
DE3872688D1 (de) Kontrollverfahren fuer einen mikrobiologischen prozess.
NO881476D0 (no) Fremgangsmaate for aa fremskaffe en skjoet mellom to fortrinnsvis roerformede gjenstander.
DE3863906D1 (de) Elektrolysezellen fuer die herstellung von fluor.
IT8619653A0 (it) Procedimento per la produzione di bussole a struttura perfezionara, per l'unione di parti in legno.

Legal Events

Date Code Title Description
BB Publication of examined application
ND Supplementary protection certificate (spc) granted
SPCG Supplementary protection certificate granted

Spc suppl protection certif: L92

Extension date: 20120313

FG Patent granted

Owner name: SCHERING AKTIENGESELLSCHAFT

MA Patent expired